These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4748428)

  • 1. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    Pazmiño NH; Yuhas JM
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J; Moloney JB; Groupé V
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Humoral reactions in BALC/c mice with sarcomatous Moloney-induced tumor].
    Yakimenko LV; Vetrova EP; Kaminskaya LP; Berdova AG; Umansky YA
    Vopr Onkol; 1979; 25(9):46-50. PubMed ID: 573520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction and regression of primary moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 Sep; 27(9):1626-31. PubMed ID: 4860892
    [No Abstract]   [Full Text] [Related]  

  • 7. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
    Law LW; Ting RC
    J Natl Cancer Inst; 1970 Mar; 44(3):615-21. PubMed ID: 11515430
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice.
    Houchens DP; Goldberg AI; Gaston MR; Kende M; Goldin A
    Cancer Res; 1973 Apr; 33(4):685-90. PubMed ID: 4696469
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA; Perk K; Turner W; Burka B; Gomez M
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The age related responses of New Zealand mice to a murine sarcoma virus.
    Gazdar AF; Beitzel W; Talal N
    Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin.
    Strausser HR; Bober LA
    Cancer Res; 1972 Oct; 32(10):2156-9. PubMed ID: 4562825
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
    Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ
    Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the growth and regression of a transplantable Moloney sarcoma.
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 Nov; 27(11):2207-11. PubMed ID: 4864248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.